Aims. This study evaluated feasibility and safety of implanting the polyester‐coated nitinol
ventricular septal defect occluder (pcVSDO) in the canine model. Methods and Results. VSD …

Current percutaneous devices for septal defect treatment are made of nondegradable
metallic and synthetic fabric materials. These devices are not ideal due to risks of future …

Background Transcatheter closure has become the method of choice for treatment of many
heart defects. Recently, Lifetech Scientific introduced the Cera occluder (CO), a self …

Objective Atrial septal defect (ASD) is a general term used to describe an opening in the
atrial septum that divides the two atria; unless the hole is occluded, it can give rise to serious …

Objective To discuss the suitable types of ventricular septal defects for asymmetric
occluders, and elucidate the critical role of echocardiography in choosing occluders, guiding …

ObjectivesThis study aimed to develop a method for retrieval of the new meshed nitinol atrial
septal defect occluders–Ceraflex and Occlutech. BackgroundThe newly developed atrial …

This study was conducted to evaluate the feasibility, safety, biocompatibility, and
degradation features of a fully biodegradable occluder for closure of atrial septal defect …

Percutaneous device closure of atrial septal defect (ASD) is now considered the choice of
treatment. Numerous devices with advantages/disadvantages are currently available and …

Atrial septal defect (ASD) and patent foramen ovale (PFO) are common clinical congenital
heart defects. As an effective method for the treatment of ASD and PFO, transcatheter …

One of the most feared complications of transcatheter closure of a perimembranous
ventricular septal defect (VSD) by the Amplatzer membranous occluder is atrioventricular …